Matthew Korenberg

(Mr. Matthew Korenberg)

Currently holds a position at Ligand Pharmaceuticals Inc

Positions

Position Company Period
Chief Financial Officer, Executive Vice President - Finance Ligand Pharmaceuticals Inc Jan. 1, 2018 -
Chief Financial Officer, Vice President - Finance Ligand Pharmaceuticals Inc Aug. 6, 2015 - Jan. 1, 2018
Matthew Korenberg's trades of Ligand Pharmaceuticals Inc's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2024-09-24 2024-09-23 S Sale
201 -0.4%
102.05
USD 20,513
201 -0.4% 102.05 USD 20,513
2024-09-24 2024-09-23 S Sale
7,090 -12.2%
101.61
USD 720,379
7,090 -12.2% 101.61 USD 720,379
2024-09-24 2024-09-23 S Sale
2,481 -4.1%
100.05
USD 248,228
2,481 -4.1% 100.05 USD 248,228
2024-09-24 2024-09-20 S Sale
6,275 -11.0%
104.10
USD 653,238
6,275 -11.0% 104.10 USD 653,238
2024-08-26 2024-08-26 S Sale
5,212 -9.5%
106.32
USD 554,147
5,212 -9.5% 106.32 USD 554,147
2024-08-26 2024-08-26 S Sale
6,177 -10.1%
105.02
USD 648,684
6,177 -10.1% 105.02 USD 648,684
2024-08-26 2024-08-23 S Sale
4,275 -6.6%
105.13
USD 449,439
4,275 -6.6% 105.13 USD 449,439
2024-08-26 2024-08-23 S Sale
2,037 -3.0%
104.09
USD 212,040
2,037 -3.0% 104.09 USD 212,040
2024-08-26 2024-08-22 S Sale
1,157 -1.7%
105.54
USD 122,110
1,157 -1.7% 105.54 USD 122,110
2024-08-13 2024-08-09 S Sale
18,245 -21.1%
98.50
USD 1,797,133
18,245 -21.1% 98.50 USD 1,797,133
2024-05-15 2024-05-14 S Sale
520 -0.6%
85.68
USD 44,556
520 -0.6% 85.68 USD 44,556
2024-05-15 2024-05-14 S Sale
13,638 -13.6%
85.08
USD 1,160,356
13,638 -13.6% 85.08 USD 1,160,356
2024-05-15 2024-05-13 S Sale
3,440 -3.3%
84.54
USD 290,828
3,440 -3.3% 84.54 USD 290,828
2019-09-03 2019-09-03 B Purchase
500 +3.0%
86.18
USD 43,091
500 +3.0% 86.18 USD 43,091
// ... existing code ... // ... rest of the file ...